Clinical Trials Logo
  1. Home
  2. Cocaine Abuse
  3. NCT00350870

CBT With Disulfiram and Contingency Management

Cocaine Abuse Clinical Trial

Official title:
Maximizing the Efficacy of Cognitive Behavioral Therapy With Medication and Contingency Management

Clinical Trial Summary

This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).

Clinical Trial Description

This study will compare four types of treatment involving skills training and incentives for attending sessions or taking study medication. Disulfiram is a widely prescribed deterrent to alcohol use. In addition to weekly cognitive behavioral therapy (CBT), participants will be assigned to one of the following treatments:

1. placebo

2. disulfiram

3. placebo plus incentives for cocaine abstinence and medication compliance (prize CM)

4. disulfiram plus incentives for cocaine abstinence and medication compliance ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00350870
Study type Interventional
Source Yale University
Contact
Status Completed
Phase Phase 1
Start date April 2005
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01601743 - Exercise as a Behavioral Treatment for Cocaine Dependence N/A
Completed NCT00217997 - Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals N/A
Completed NCT00227903 - Therapeutic Substance Abuse Treatment in Pregnancy - 1 Phase 2
Terminated NCT00142883 - The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 N/A
Completed NCT00842517 - Long Term Maintenance of Drug Abstinence Phase 1
Completed NCT02563769 - Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study Phase 1
Completed NCT01651377 - Pramipexole as a Treatment for Cocaine Dependence Phase 1
Recruiting NCT00439049 - Substance Abuse Pre-Treatment Screening Study
Completed NCT00249457 - Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 N/A
Completed NCT01401270 - Prize Contingency Management for Cocaine-Dependent Methadone Patients N/A
Completed NCT00350610 - Computer-Based Training in Cognitive Behavior Therapy Phase 1
Recruiting NCT06177860 - Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Completed NCT02393599 - Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin Phase 1
Completed NCT02141620 - n-Acetylcysteine and Cocaine Phase 0
Recruiting NCT00218023 - Medications for Stopping Cocaine Dependence and Preventing Relapse Phase 2
Completed NCT00218075 - Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence Phase 2
Recruiting NCT05857852 - Low-Intensity Focused Ultrasound for Cocaine Use Disorder N/A
Completed NCT00606801 - Galantamine Effects on Cognitive Function in Abstinent Cocaine Users N/A
Completed NCT00292123 - Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse Phase 1
Completed NCT00318760 - Effect of Clonidine on Responses to Imagery Scripts Phase 1